Reliable Adverse Event Incidence Data Would Benefit Industry - Woosley
Executive Summary
Reliable adverse event incidence data would benefit industry by saving money spent on large-scale trials, Raymond Woosley, MD/PhD, Georgetown Medical Center, said at a conference on adverse drug events Feb. 24.